Early Immune System Development and Ontogeny (R01 Clinical Trial Optional)
up to $40,000,000 Due in 870 days

Early Immune System Development and Ontogeny (R01 Clinical Trial Optional) The purpose of this Notice of Funding Opportunity (NOFO) is tofurther elucidate the mechanisms of early immune development in utero, during the early post-natal period and during early …

Ask me anything about applying to this grant — your fit, eligibility, or how to start your narrative.

One free message · powered by Grantable AI

Grantable

Welcome to Grantable

Sign in to start building your grant-ready profile

or

We'll send you a one-time verification code. No password needed. By signing in you agree to our Terms of Service and Privacy Policy.